Cannabis-Derived Drug Shows Promise in Brain Cancer Study
Brain Cancer Study British-based GW Pharmaceuticals received more good news regarding its cannabis-based drug development efforts. The drug-maker published positive Phase 2 data from an exploratory placebo-controlled study te ...